Rhinoplasty (코성형).

Rhinoplasty reshapes the nasal structure. In Korean practice the major sub-procedures are tip plasty (코끝성형) — reshaping the soft cartilage at the tip; bridge augmentation (콧대성형) — raising the nasal dorsum with an implant or cartilage graft; and alar reduction (콧볼축소) — narrowing the nostril base. Most Korean rhinoplasty cases combine two or three of these.

Silicone implants are the most common for bridge augmentation in Korean practice — a long track record, low cost, removable if needed. Gore-Tex (ePTFE) is a softer alternative with a different feel. Autologous cartilage (from the septum, ear, or rib) avoids implant materials entirely and is often combined with silicone for tip refinement. Donor cartilage (irradiated rib) is used in some revision cases. The choice matters — ask the surgeon to explain theirs.

Material choice and why. Whether 3D imaging is used for planning. Anesthesia type — most Korean clinics do rhinoplasty under general anesthesia with a licensed anesthesiologist; sedation is an option for tip-only work. Revision policy: what happens if the implant deviates, gets infected, or the shape needs adjustment. The surgeon's specific volume for your planned combination.

The cast stays on for 5–7 days. Visible swelling and bruising peaks at day 3–4, subsides materially by day 10. The tip shape continues to settle for 6–12 months — the version you see at 3 weeks is not the final version. Nasal breathing returns progressively over the first 3–6 weeks.

Tip plasty alone: ₩2,000,000–₩5,000,000. Primary bridge + tip: ₩3,000,000–₩8,000,000. Full combined case with septum work or autologous cartilage: ₩6,000,000–₩12,000,000. Revision rhinoplasty: 20–50% above primary pricing.

"What's your personal revision rate for primary rhinoplasty, and how many of yours have required a second surgery?" Every high-volume surgeon has some revisions. A surgeon who claims zero is either brand-new or not answering the question.

Most Korean rhinoplasty (코성형) is performed under general anesthesia with intubation rather than the light sedation used for double eyelid surgery. Arrival at the clinic usually involves a final markup with the surgeon, a consent re-check, and a change into a hospital gown. The IV is placed in a pre-op room; induction itself is unmemorable — patients describe counting backwards from ten and getting to seven. The procedure typically takes two to four hours depending on whether tip work (코끝성형), bridge augmentation (콧대성형), or alar reduction (콧볼축소) are combined.

Waking up is the part most patients underestimate. The external cast or splint is already in place, the inside of the nose is packed with silicone or absorbable splints, and breathing has to happen through the mouth. The throat feels raw from the breathing tube. There is a metallic taste at the back of the throat from dried blood, and a faint iron smell that lingers for two to three days. Day 1 is the heaviest: pressure across the bridge, a dull ache rather than sharp pain, and the awareness that any small head movement is felt. Sleeping propped at 45 degrees is mandatory.

By day 7, most clinics remove the cast and internal splints. The first breath through the nose after splint removal is the moment patients remember — air moves through swollen passages, often with whistling, but it moves. The bridge looks higher and narrower than it will eventually settle. By week three the major bruising has gone; full settling of the tip continues for 6 to 12 months.

Asian rhinoplasty is one of the most-published areas in facial plastic surgery, and the literature gives a consistent picture: serious complications are uncommon, but minor revisions and implant-related issues are not. A multicenter Korean study by Jin and colleagues (PMID: 17181104) followed 853 patients (656 primary, 197 secondary) using expanded polytetrafluoroethylene (Gore-Tex) over an average 18-month follow-up and reported infection in 2.1% overall — 1.4% in primary cases and 4.6% in secondary cases — with graft removal required in 91% of infected cases. A separate series of 177 Asian patients undergoing primary or secondary rhinoplasty with silicone-polytetrafluoroethylene composite implants (PMID: 26999716) reported a 10.7% complication rate, comprising malposition or deviation in 4.5%, erythema in 2.3%, and infection in 1.1%.

On autologous cartilage, a published Korean series of 83 cases using costal cartilage (PMID: 23190817) reported a 12% graft-related complication rate, including five warped grafts and five infections. A more recent systematic review and meta-analysis comparing autologous versus irradiated homologous costal cartilage (PMID: 39896219) reported comparable warping rates between the two materials, with comparable resorption and infection profiles overall. Capsular contracture remains the dominant long-term concern with silicone implants, and a published classification and treatment algorithm (PMC5300926) catalogues four contracture stages and the corresponding revision approach.

Vision-threatening complications — orbital cellulitis from contiguous infection, retrobulbar haematoma, sudden vision loss — are rare in the published Korean literature but are documented. Revision rates across Asian rhinoplasty series cluster between 5% and 15% depending on case mix and follow-up length. None of these numbers replace a personal pre-op assessment. Ask your surgeon for their own audited revision and infection rate, in writing, and ask which implant or graft material they default to, and why.

Changing the nasal silhouette changes how the rest of the mid-face is read. A higher bridge brings the eyes visually closer together, even when the inter-canthal distance is unchanged. A more projected, defined tip pulls the visual centre of the face forward, which can make the chin look slightly recessed by comparison — even when the chin has not been touched. This is why some Korean clinics offer chin filler or genioplasty consultations alongside rhinoplasty: not because the chin has changed, but because its visual relationship to the new nose has.

What rhinoplasty does not do is more important. It does not change ethnicity. The Korean preference, well-documented in published Asian rhinoplasty reviews (PMID: 34579840), is a defined, conservatively augmented profile with a refined tip — not a Western nose. Going in with reference photos that contradict your underlying bone and skin thickness tends to produce the dissatisfaction the literature describes. It does not correct facial asymmetry that comes from underlying jaw or maxillary asymmetry; the nose can be straightened, but a deviated chin or uneven cheekbones remain. It does not improve breathing unless functional rhinoplasty addresses the septum or turbinates — cosmetic-only augmentation can in some cases narrow internal valves and make breathing worse rather than better.

Skin thickness is the single most under-discussed limiter. Thick sebaceous tip skin will not show definition the way thin skin does, regardless of the underlying cartilage work. Discuss with your surgeon what your skin envelope can actually display, and ask to see un-retouched 6 to 12 month results on patients with similar skin to yours.

Long-term outcome data for Asian rhinoplasty have improved markedly since the FACE-Q rhinoplasty module became the standard patient-reported instrument. The original FACE-Q rhinoplasty validation (PMID: 25919265) demonstrated significant post-operative gains across satisfaction with facial appearance, psychological well-being, and social function in 56 patients followed pre- and post-operatively. A larger Chinese cohort of 707 rhinoplasty patients evaluated with the same instrument (PMID: 35882242) reported satisfaction rates of 98.4% in men and 96.9% in women at a median 1-year follow-up, with men more often dissatisfied pre-operatively with the bridge and women more often with the tip.

Korean groups have published extensively on structural techniques. A Seoul series of 774 patients undergoing septorhinoplasty with polycaprolactone mesh between 2017 and 2019 (PMID: 34161991) reported high satisfaction in both composite and mesh-only groups and a low revision rate overall, with no major complaint regarding tip flexibility. The septal extension graft, now a default Korean technique for short-nose correction, was characterised in an East Asian series (PMID: 24511490) showing stable tip projection and naso-labial angle correction in long-term follow-up. A review of cosmetic augmentation rhinoplasty for East Asians (PMID: 34579840) documents the shift away from pure alloplastic implants toward hybrid autologous-alloplastic constructs over the past decade.

On the bone-work side, a 734-patient series of closed-approach preservation rhinoplasty using piezoelectric instruments (PMID: 39812015), published in Aesthetic Surgery Journal in 2025, reported a 6% revision rate, predominantly for dorsal contour adjustments, with reduced intra-operative bleeding and post-operative pain compared with conventional osteotomies. The takeaway across these studies is that satisfaction scores are high when the technique is matched to the anatomy, the surgeon is experienced with Asian noses specifically, and expectations are calibrated against published outcomes rather than edited social-media images.

Korean rhinoplasty has shifted in two directions over the past five years. The first is preservation rhinoplasty, the post-2020 movement that minimises dorsal hump removal in favour of pushing the existing dorsum down and preserving its native shape. The 2025 piezo-assisted closed-approach series (PMID: 39812015) is the largest Korean-relevant preservation cohort published to date. The second is ultrasonic rhinoplasty itself: PEAK and similar piezoelectric devices replace the older osteotome-and-mallet bone work, which most Korean clinics now describe as standard of care for primary cases involving osteotomies. Patients ask less about implant material and more about whether the clinic uses ultrasonic instruments, which is a reasonable question to raise during consultation.

Around the procedure, the Korean recovery market has expanded. Hyaluronic acid filler nose — the so-called non-surgical rhinoplasty, a high-volume search term — is offered by most aesthetic clinics for patients who want a bridge or tip preview before committing to surgery, or who want a small touch-up rather than a full korean nose job. PDRN (polydeoxyribonucleotide, derived from salmon DNA) injections and topical PDRN are routinely offered post-cast to support skin recovery, though clinical evidence in this specific indication is still early. The glass skin endpoint — clear, light-reflecting skin — frames how patients judge the post-op face: not just shape, but surface. Exosome facials, offered in many Gangnam clinics from 2024 onwards, are marketed as recovery accelerators; published data in this indication remain limited, and patients should ask whether the clinic uses regulated, traceable products. None of these add-ons replace the fundamentals — sun avoidance, no glasses pressure, no nose-blowing for the first weeks. Treat them as optional, not as substitutes.

Will I be under general anesthesia? In most Korean clinics, yes — primary rhinoplasty is typically performed under general anesthesia with intubation. Some short, filler-only or minor tip revisions can be done under deep sedation; ask your surgeon which protocol applies to your case.

How long is the cast on? Usually 5 to 7 days for the external cast, and any internal silicone splints are removed at the same visit. Suture removal at the columella, if open approach, follows on the same schedule.

Can I fly home with the cast on? Most Korean surgeons advise waiting until at least the cast-removal visit before flying, both for swelling management and because cabin pressure changes are uncomfortable on a freshly operated nose. Plan a minimum 7 to 10 day stay, longer if combined procedures.

Will I be able to breathe normally after? Once swelling resolves, yes — but full internal swelling can take 3 to 6 months to settle. If you had a cosmetic-only augmentation, breathing is unchanged from baseline. If septal correction was included, breathing is usually improved.

Will my voice change? A subtle, temporary change in nasal resonance is normal during the first weeks while the nose is swollen and packed. Long-term voice change is not expected from standard rhinoplasty.

Can I wear glasses after? Bridge implants and osteotomies need glasses-frame protection for around 6 weeks; most surgeons recommend taping the frames to the forehead, switching to contact lenses, or using a lightweight nose-bridge spacer. Discuss with your surgeon at the post-op visit.

How long until I can wear makeup? Around the nose itself, usually 2 weeks once the cast is off and sutures have been removed. Eye and lip makeup can resume earlier, depending on the clinic's protocol.

Will my smile look different temporarily? Yes — tip swelling and tension on the columella can stiffen the upper lip for the first 4 to 6 weeks, and smiling can feel restricted. This typically resolves on its own.

Can I combine with double eyelid surgery in one session? It is one of the most common combinations in Korea. The trade-off is a longer single recovery window and a longer anesthesia time. Ask your surgeon whether your specific procedures justify combining or staging.

Will I need revision in the future? Published Asian rhinoplasty revision rates cluster between 5% and 15% depending on technique and follow-up length. Implant-related issues — capsular contracture, displacement, late infection — can present years after the primary surgery. Ask your surgeon how they handle revisions and whether their fee includes minor touch-up work within a defined window.